Bio Green Med Solution Inc

Finanzen von Bio Green Med Solution Inc (CYCC)

$6.365

-0.381 (-5.98%)Zum Schluss

Profitabilität und Margen von CYCC

Evaluating the bottom line, Bio Green Med Solution Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -277.85%, provide a clear picture of how effectively CYCC converts its operational activities into shareholder value.

CYCC im Vergleich zur Peergroup

In the context of the broader market, CYCC competes directly with industry leaders such as APM and NXTC. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, CYCC's gross margin of N/A stands against APM's N/A and NXTC's N/A. Such benchmarking helps identify whether Bio Green Med Solution Inc is trading at a premium or discount relative to its financial performance.

Financials

FY2025Q2
YoY:
-100.00%
0.00
Total Revenue
FY2025Q2
YoY:
-63.86%
-1.32M
Operating Profit
FY2025Q2
YoY:
-59.53%
-1.32M
Net Income after Tax
FY2025Q2
YoY:
-99.43%
-0.98
EPS - Diluted
FY2024Q3
YoY:
-24.01%
-3.07M
Free Cash Flow
FY2024Q4
YoY:
0.00%
100.00
Gross Profit Margin - %
FY2024Q3
YoY:
+218.97%
-14.25K
FCF Margin - %
FY2024Q4
YoY:
+53.35%
-26.07K
Net Margin - %

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten